Campaner, Ermita A.

HRN: 22-08-61  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/13/2026
CEFTRIAXONE 1G (VIAL)
08/13/2026
08/20/2026
IV
2g
OD
Lacerated Wound Temporo-orbital Area
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: